Similar Articles |
|
Pharmaceutical Executive January 1, 2013 Al Topin |
The Doctor-Patient Disconnect Doctor-patient conversations aren't always what we think; this basic interaction represents both a problem and an opportunity for today's drug marketers, says the author. |
Pharmaceutical Executive July 3, 2007 LeVine & Zucker |
Marketing to Professionals: Professional Promotion Through Patient Understanding Patient-feedback programs can go a long way in helping physicians understand which drugs work. |
Pharmaceutical Executive March 1, 2013 Al Topin |
Less Selling, More Time What can happen when pharmaceutical reps focus on the physician-patient conversation? |
Pharmaceutical Executive September 1, 2012 Al Topin |
Doctors' Words No Longer Gospel In the digital age, physicians don't call the shots when it comes to healthcare guidance. Marketers must appeal to multiple sources in seeking ways to garner patient adherence and loyalty. |
Pharmaceutical Executive January 1, 2006 Gina Ashe |
Alternative Media: Patient Bloggers on Your Brands Find out what patient bloggers are saying about your pharmaceutical brands. |
Managed Care March 2005 Martin Sipkoff |
Direct-to-Consumer Ads Garner Mixed Outcomes DTC advertising's reputation as a bully may be largely overstated. There's little evidence that sales of specific drugs increase, and there may be some benefit. |
American Family Physician November 15, 2005 Haas et al. |
Management of the Difficult Patient All physicians must care for some patients who are perceived as difficult because of behavioral or emotional aspects that affect their care. Specific communication techniques and greater patient involvement in the process of care may enhance the relationship. |
Managed Care October 2002 Pamela L. Popp |
How To -- And Not To -- Disclose Medical Errors to Patients Health care facilities and physician practices must commence development and implementation of a disclosure policy. The policy should include a statement of the need and willingness of the patient and physician to have an open and honest relationship and a constant dialogue. |
Pharmaceutical Executive October 1, 2011 |
Arming up for the Digital Revolution As a longtime advocate of new approaches to meeting customer needs in pharma, Martin Wygod sees the biggest change as the coming growth of digital platforms as the principal source of information and communication in healthcare. |
Pharmaceutical Executive July 1, 2012 Al Topin |
Marketing: Why the Conversation Has Changed -- Forever At its core, pharma marketing is about conversations. Dynamic, persuasive conversations between companies and healthcare stakeholders. But one time it was simple; now it's not. |
Pharmaceutical Executive May 1, 2006 Musacchio & Hunkler |
More Than a Game of Keep Away The Prescribing Data Restriction Program takes effect in July. The AMA explains how individual doctors can keep their prescribing habits safe from reps, and how pharma can keep using the anonymous data -- if the industry polices itself. |
Pharmaceutical Executive October 1, 2006 Gary Norman |
Direct to Consumer: If These Walls Had Ears New research shows how DTC affects patients' conversations with physicians. |
CIO October 29, 2015 Martha Heller |
Amgen uses algorithms to venture into digital healthcare A senior vice president of global marketing and commercial development, says she's working with the CIO to set up a digital healthcare organization that can help physicians better predict how patients will respond to therapies. |
Pharmaceutical Executive December 1, 2006 Marcee Nelson |
Direct to Consumer: Don't Wait By stocking waiting rooms with educational drug information, pharma can help get doctor-patient communication off on the right foot. |
Pharmaceutical Executive March 1, 2012 Paolo De Marino |
Registering Value: Always in the Eye of the Beholder The organizational disconnect between marketing and market access is curable if both groups focus on what counts: who's making the final purchase. |
Pharmaceutical Executive May 1, 2005 Ame Wadler |
PR: In the Loop Pharma marketers can help doctors stay abreast of the news. |
Pharmaceutical Executive April 1, 2006 David Duplay |
Marketing to Professionals: A Sample Plan Sure, pharmaceutical e-sampling can save money. But there are plenty of other reasons to use it. |
Pharmaceutical Executive September 1, 2005 Nickum & Kelly |
Missing the Mark(et) Pharmaceutical companies spend billions on data. Sales reps crowd the waiting rooms. So why is the doctor out? |
Pharmaceutical Executive September 1, 2006 Richard B. Vanderveer |
The Information Diet How, when, and why physicians consume information. |
American Family Physician February 1, 2005 Searight & Gafford |
Cultural Diversity at the End of Life: Issues and Guidelines for Family Physicians When considering therapeutic options, physicians should consider that members of many cultural groups prefer that family members, rather than patients, make treatment decisions. |
Managed Care June 2007 Lola Butcher |
What the Devil Is Information Therapy? Welcome to information therapy, the practice of providing more and better information to patients so they can contribute more to their healing. |
Pharmaceutical Executive January 1, 2006 Gene Guselli |
Marketing to Professionals: The Power of Positive Feedback Boost doctors' confidence in your brand by validating their prescription decisions. |
Pharmaceutical Executive October 1, 2008 Andrew Levitt |
What's The Buzz What's the buzz all about? Word of mouth is more effective than we think. |
Pharmaceutical Executive September 1, 2013 Ben Comer |
Share of Screen: Prioritizing Electronic Health Records Are electronic health records a viable channel for engagement? |
Pharmaceutical Executive January 1, 2012 Elys Roberts & Sarah Phillips |
The Emergence of the Pro-Patient How can pharma embrace and interact with increasingly informed and demanding patients to bring positive outcomes for all? |
Pharmaceutical Executive October 1, 2005 Mike Iafolla & Steve Greco |
Under the Influence The number of influences that affect physicians' prescribing has increased and rep saturation has reached the tipping point, resulting in "customer fatigue." Companies must now take into account a plethora of influences when planning their sales and marketing efforts. |
HBS Working Knowledge November 1, 2004 Manda Salls |
Bypass Marketing: Are Docs Influenced? Does direct-to-consumer advertising inform or persuade consumers about prescription drugs? Do physicians prescribe brands based on their patients' requests? Two Harvard professors discuss their study, which recently investigated these questions. |
American Family Physician September 1, 2000 Cheryl Winchell, M.D. |
Curbside Consultation What to do when a patient makes inappropriate, seductive advances to you, his/her physician... |
Pharmaceutical Executive March 1, 2011 Jerry Coamey |
Engage the Physician! New research shows that gauging the mind of the clinician is crucial to timely uptake of the new diagnostic tools offered by the genomic revolution |
Pharmaceutical Executive July 3, 2007 Jessica DiPaolo |
Toolkit: Good Tailoring Does your marketing campaign reach the huddled masses of frustrated or illiterate healthcare consumers? |
American Family Physician October 15, 2005 Coleman & Newton |
Supporting Self-Management in Patients with Chronic Illness Family physicians can support patient self-management by structuring patient-physician interactions to identify problems from the patient perspective, making office environment changes that remove self-management barriers, and providing education individually and through available community self-management resources. |
Managed Care June 2005 Martin Sipkoff |
The Re-Emergence of the Primary Care Physician A new model of care developed by the American Academy of Family Physicians places primary care physicians back at the center of care delivery. |
Pharmaceutical Executive March 1, 2006 Sharyn Lee |
Invisible Prescribers: What You Do and Don't Know About NPs and PAs How many prescriptions are written each year by nurse practitioners and physician assistants? Pharmaceutical companies not only fail to market to this sector, they neglect to invite nurse practitioners and physician assistants to meetings or to include them in plans for continuing medical education. |
Pharmaceutical Executive September 1, 2008 Jeffrey S. Aronin |
The Orphan Opportunity The Orphan Drug Act was passed 25 years ago. But the challenge of actually getting rare disease drugs and therapies to patients still remains |
Pharmaceutical Executive April 1, 2009 Marcee Nelson |
Ten Minutes to Connect What women are looking for in their physician's office is less consultation and more conversation. |
Pharmaceutical Executive June 1, 2006 Anne Goodrich |
Marketing to Professionals: Doctors Get Jump on Continuing Education Doctors turn to multiple CME channels for more than just credits. |
Pharmaceutical Executive January 1, 2007 Jeffrey Zornitsky |
Sales Management: Get Committed By better managing relationships with physicians, pharma companies can develop a base of dedicated prescribers. |
Pharmaceutical Executive March 1, 2006 Dorfman & Maynor |
Marketing to Professionals: Under the Influence Pharmaceutical marketers should target the doctors who affect change in the medical community. |
Managed Care May 2006 |
Physician Disclosure Strengthens Patients' Trust Patients who received a disclosure felt more competent to judge the effect of their physician's compensation on their health care, and nearly a quarter of patients who remembered receiving a disclosure reported that it had increased their trust in their primary care physician. |
Pharmaceutical Executive May 1, 2012 |
The Personal Touch in Digital Promotion The shift from sales rep meetings to digital selling methods must include innovation and a physician-centered mindset in order to be successful. |
American Family Physician April 1, 2002 Forrest Lang |
Interviewing When Family Members Are Present The presence of family members at an office visit creates unique opportunities and challenges for the physician while interviewing the patient. The physician must address issues of confidentiality, privacy, and agency... |
Managed Care April 2004 Martin Sipkoff |
Plans Go Directly to Patients, Describing Treatment Options HMOs are developing programs that encourage patients to question their physicians about their treatment options. Doctors are wary. |
Managed Care June 2007 |
Docs Don't Exploit Electronic Prescribing While physicians were positive about the basic features of e-prescribing, products often lacked advanced features, or if they had them, physicians often did not use them because of implementation hurdles or their perceptions that the features did not add value. |
American Family Physician August 15, 2004 Lang & Quill |
Making Decisions with Families at the End of Life Because advance directives are not yet the norm, end-of-life decisions for patients without medical decision-making capacity are made regularly within discussions between the patient's physician and family. |
Pharmaceutical Executive February 1, 2012 Sarah Krug |
Introducing the 'Chief Patient Officer' Now is the time for pharma companies to appoint a Chief Patient Officer, a new position designed to build an accord around patient trust. |
Pharmaceutical Executive June 1, 2005 Boschwitz et al. |
Track Patients, Not Prescriptions Why pharma companies reject anonymous patient-level data, and why they can't do without it for long. |
Pharmaceutical Executive January 1, 2006 Maggie Helmig |
Direct to Consumer: Patient Education Reform Marketers can empower patients to start a dialogue with their doctors. |
Managed Care August 2001 |
In Calif., Bonuses Based on Quality, Not Cost Savings Blue Cross of California has decided to move away from the traditional managed care incentive of rewarding physicians for controlling medical costs, and instead will implement a program in which physicians receive bonuses for quality of care and patient satisfaction... |
American Family Physician October 1, 2000 |
AAFP Core Educational Guidelines Recommended Core Educational Guidelines For Family Practice Residents... |
Managed Care February 2001 Christopher M. Dezii |
Persistence With Drug Therapy A practical approach using administrative claims data... |